Evaluation of JAK2V617F in B and T Cell Neoplasms: Identification of JAK2V617F Mutation of Undetermined Significance (JMUS) in the Bone Marrow of Three Individuals-Reference-Cited by-同舟云学术

Evaluation of JAK2^V617F in B and T Cell Neoplasms: Identification of JAK2^V617F Mutation of Undetermined Significance (JMUS) in the Bone Marrow of Three Individuals

Published:2007 Issue:4 Volume:118 Page:209-214
ISSN:0001-5792
Container-title:Acta Haematologica
language:en
Short-container-title:Acta Haematol

Author:

Wang Y. Lynn,Lee Joong W.,Kui Jonathan S.,Chadburn Amy,Cross Nicholas C.P.,Knowles Daniel M.,Coleman Morton

Publisher

S. Karger AG

Subject

Hematology,General Medicine

Reference22 articles.

1. Fusion of TEL, the ETS-Variant Gene 6 (ETV6), to the Receptor-Associated Kinase JAK2 as a Result of t(9; 12) in a Lymphoid and t(9; 15; 12) in a Myeloid Leukemia

2. The t(8;9)(p22;p24) Is a Recurrent Abnormality in Chronic and Acute Leukemia that Fuses PCM1 to JAK2

3. A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma

4. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of CD markers in JAK2V617F positive myeloproliferative neoplasms: Prognostic significance;Oncology Reviews;2018-10-02

2. Bone marrow fibrosis in chronic myelomonocytic leukemia is associated with increased megakaryopoiesis, splenomegaly and with a shorter median time to disease progression;Oncotarget;2017-10-17

3. Success of interferon α therapy in a patient with hepatitis C virus-negative splenic marginal zone lymphoma associated with polycythemia vera;Leukemia & Lymphoma;2015-03-06

4. JAK2 V617F detected in two B-cell chronic lymphocytic leukemia patients without coexisting Philadelphia chromosome-negative myeloproliferative neoplasms: A report of two cases;Oncology Letters;2014-05-22

5. A rare case of primary cutaneous follicle centre lymphoma presenting as a giant tumour of the scalp and combined with JAK2V617F positive essential thrombocythaemia;Biomarker Research;2014-04-01